AI in Radiology

Overview

AI in radiology includes detection classification and workflow tools. It can improve efficiency and support diagnostic accuracy. Clinical integration requires validation and oversight.

Detection and Triage

AI algorithms can flag critical findings and prioritize studies for review. Triage tools reduce time to diagnosis for urgent cases. Human oversight remains essential for final interpretation.

Quantification and Segmentation

AI automates segmentation and quantitative analysis of structures and lesions. These tools support treatment planning and monitoring. Standardized validation ensures reliability across populations.

Regulatory and Ethical Issues

Regulatory approval and ethical use are central to AI deployment. Transparency and bias mitigation are important for trust and safety. Ongoing evaluation monitors performance in clinical practice.

AI for PET Quantification

Overview

AI enhances PET image reconstruction quantification and lesion detection. It improves signal to noise and enables lower dose tracer protocols. Quantitative PET metrics support therapy monitoring.

Attenuation Correction

AI predicts attenuation maps from non contrast data to improve PET quantification. Accurate correction reduces bias in standardized uptake values. Validation across scanners and tracers is required.

Lesion Detection

AI assists in automated lesion segmentation and SUV measurement. It supports longitudinal comparison and response assessment. Integration with hybrid imaging improves localization.

Clinical Impact

Improved quantification enhances treatment planning and response evaluation. Standardized workflows enable multicenter studies and trials. Regulatory acceptance depends on demonstrated clinical benefit.

Nuclear Medicine Journal

Overview

Nuclear Medicine Journal focuses on tracer development theranostics and quantitative PET SPECT methods; it highlights translational studies and clinical trials; articles emphasize dosimetry standardization and multicenter harmonization.

Tracer Development

Papers describe novel radiotracers for oncology neurology and cardiology; radiochemistry methods and production logistics are detailed; clinical translation challenges and regulatory pathways are discussed.

Quantification and Standards

Studies address SUV harmonization kinetic modeling and cross center calibration; guidelines for quantitative PET SPECT are proposed and validated; reproducible methods and phantom based QA are emphasized.

Theranostics and Therapy

Research on targeted radiopharmaceutical therapy and imaging biomarkers is featured; clinical outcomes safety and patient selection criteria are reported; multidisciplinary collaboration with oncology is highlighted.

Nuclear Medicine Magazine

Overview

Nuclear Medicine Magazine covers tracer development theranostics and quantitative imaging; it highlights clinical trials and translational research; articles support nuclear medicine physicians and technologists.

Tracer Innovation

Features describe novel PET and SPECT tracers for oncology and neurology; radiochemistry and logistics are discussed; clinical translation challenges are explored.

Theranostics

Coverage includes targeted radiopharmaceutical therapy and patient selection; safety and dosimetry considerations are presented; outcomes and case series illustrate therapeutic impact.

Quantitative Practice

Articles address SUV harmonization kinetic modeling and cross center calibration; best practices for quantitative PET are shared; readers learn methods to improve reproducibility.